Robert Weinreb, MD
Enriched profileChair and Distinguished Professor, Viterbi Family Department of Ophthalmology; Director, Shiley Eye Institute; Director, Hamilton Glaucoma Center; Morris Gleich, MD Chair of Glaucoma; Distinguished Professor of Bioengineering · University of California San Diego
Robert Weinreb is Chair and Distinguished Professor, Viterbi Family Department of Ophthalmology; Director, Shiley Eye Institute; Director, Hamilton Glaucoma Center; Morris Gleich, MD Chair of Glaucoma; Distinguished Professor of Bioengineering at University of California San Diego. OpenAlex indexes 1,579 publications with 71,138 citations (h-index 128); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Robert Weinreb, MD, is Chair and Distinguished Professor, Viterbi Family Department of Ophthalmology at University of California San Diego (Shiley Eye Institute / Viterbi Family Department of Ophthalmology). The public record shows 1,579 publications with 71,138 citations (h-index 128), centered on Glaucoma and retinal disorders, Retinal Diseases and Treatments, Corneal surgery and disorders. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 11 companies, 9 NIH-funded awards (1985–2025).
- Most recent indexed publication: 2026 · The British journal of ophthalmology
- Top research focus: Glaucoma and retinal disorders
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 44 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 897.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Subconjunctival Versus Direct Mitomycin C in Trabeculectomy
Sponsor: University of California, San Diego
- Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity
Sponsor: University of California, San Diego
Industry payments
Updated 27 Aug 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- TOPCON HEALTHCARE, INC.Program year202551 payments$136,679openpaymentsdata.cms.gov ↗
- Topcon Healthcare, Inc.Program year202513 payments
- TOPCON CORPORATIONProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
90.8%Prostaglandin Analog50.2%Latanoprost86%Lumigan8%Travoprost3%Tafluprost2%Travatan Z1%Part D<11 patientsCarbonic Anhydrase Inhibitor26.8%Dorzolamide-Timolol75%Dorzolamide Hcl14%Brinzolamide6%Simbrinza5%Part D<11 patientsCardiovascular
7.2%Beta blocker7.2%Timolol Maleate100%Part D≥87 patientsCancer & immunology
2%Nucleoside Metabolic Inhibitor2%Fluorouracil100%Part B, office-administered≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 1985–2025 per NIH RePORTER. The latest:
- Ophthalmology and Visual Sciences Career Development K12 Program
University of California, San Diego
FY2025$1K12EY024225 - Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography
University of California, San Diego
FY2024$691,680R01EY029058 - iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities
University of California, San Diego
FY2024$509,187R01MD014850
Congress activity
Updated 27 Aug 2026
1 congress contribution (2023) across ADA per OpenAlex. The most recent:
- 207-LB: Association of Metformin Use with Primary Open-Angle Glaucoma among Patients with Diabetes Mellitus Using Data from the National Institutes of Health All of Us Program
ADA Scientific Sessions
ADA2023Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Retinal nerve fibre layer optical texture analysis: retinal nerve fibre bundle defect patterns and the extent of macular involvement across different stages of glaucoma.
The British journal of ophthalmology
Article2026 - Initial circumpapillary retinal nerve fibre layer rates of change predict glaucomatous progression.
Eye (London, England)
Article2025 - Generative AI enables medical image segmentation in ultra low-data regimes.
Nature communications
Article2025
Most-cited works
by citation count (OpenAlex)- 01The Pathophysiology and Treatment of GlaucomaArticle4,117 citations2014
- 02Primary open-angle glaucomaArticle2,229 citations2004
- 03Primary open-angle glaucomaArticle662 citations2016
- 04
- 05Prevalence of Ocular Surface Disease in Glaucoma PatientsArticle627 citations2008
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/robert-weinreb-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Robert-Weinreb
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/UCSDShileyEye/photos/sei-is-proud-to-recognize-chair-director-robert-n-weinreb-md-for-being-ranked-nu/1295289021808262
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/UCSDShileyEye/posts/just-published-robert-n-weinreb-md-led-sei-clinician-scientists-in-collaboration/1257324728938025
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - LinkedIn
linkedin.com/posts/eyenovia_robert-weinreb-md-is-a-valued-member-or-our-activity-7052646316916584449-qppJ
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomatoday.com ↗
- Electrical Engineering studies
Massachusetts Institute of Technology (MIT)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →glaucomatoday.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ois.net ↗
Editorial & leadership roles
journal and society appointments- Co-Editor
Journal of Glaucoma
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.com ↗ - Chief Editor
International Glaucoma Review
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.com ↗ - Member
Editorial Board, Investigative Ophthalmology and Visual Science
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.com ↗
Awards & honors
honors on the public record- WGA Laureate Award
World Glaucoma Association (2023), lifetime achievement in glaucoma research and care, third-ever recipient
2023provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →powerlist.theophthalmologist.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →glaucomatoday.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →powerlist.theophthalmologist.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globenewswire.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amydis.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomatoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.expertscape.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iheart.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jay Giedd, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Igor Grant, MD
University of California San Diego
Mark Ginsberg, MD
University of California San Diego